Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Wearable Technology and Its Role in Neurologic Care
Benish, Sarah M. , Friedman, Daniel , Merchant, Sana, Louis, Erik K. St. , Patel, A., Patel, Anup D. , Merchant, Sara , Minen, Mia T , St Louis, E K , Patel, Anup D , Minen, Mia T.

Mayo Clinic

Neurology | March 11, 2026 | Volume: 106 | Issue: 7 | Pages: No page available

10.1212/wnl.0000000000214802 | PMID 41812085 Get It

Dietary Intake of Macronutrients and Micronutrients in Women with Functional Hypothalamic Amenorrhea
Uddenberg, Erin R, Safwan, Nancy , Castaneda, Regina , Saadedine, Mariam , Maughan, Jenna , Andrade, Maria D. Hurtado, Pisarska, Margareta D. , Berga, Sarah L. , Manson, James, Merz, C. Noel Bairey, Shufelt, Chrisandra , Hurtado Andrade, Maria D, Shufelt, Chrisandra L , Castaneda, Regina , Faubion, Stephanie S. , Manson, JoAnn E., Merz, C. Noel Bairey

Mayo Clinic

Journal of Women's Health | March 11, 2026 | Volume: 35 | Issue: 7 | Pages: 662-669

10.1177/15409996261428013 | PMID 41804259 Get It

Background: Functional hypothalamic amenorrhea (FHA) is a common form of secondary amenorrhea caused partly by undernutrition relative to demand. Objective: To compare the dietary nutritional intake between women with FHA and eumenorrheic controls and evaluate micronutrient profiles. Methods: This cross-sectional study included 30 women with FHA and 29 eumenorrheic controls not on hormones. FHA was defined as ≥3 consecutive months of amenorrhea, estradiol of <50 pg/mL, and FSH and LH of <10 mIU/L, excluding other etiologies. A 3-day food diary was collected for dietary analysis, excluding dietary supplements using ESHA Research Food Processor. Results: The mean age of women with FHA and controls was 26.4 years ± 6.2 versus 30.3 years ± 3.7 ( p = 0.002), with no differences in BMI ( p = 0.16) or the waist-to-hip ratio ( p = 0.71). Women with FHA and controls consumed comparable median calorie intake (1784 kcal [1465, 2011] vs. 1732 kcal [1578, 1982], p = 0.62), with no differences in self-reported exercise patterns. Women with FHA consumed more dietary protein (84.2g [74, 112] vs. 74 g [59, 92], p = 0.001) and dietary fiber (30.1 g [22, 43] vs. 17.3 g [15, 23], p = 0.02) versus controls, respectively. When expressed as a percentage of estimated average requirements (% estimated average requirement), women with FHA had higher intakes of vitamin A (105% [45, 219] vs. 43% [21, 86], p = 0.005), vitamin C (201% [139, 351] vs. 107% [75, 190], p = 0.004), and iron (169% [146, 220] vs. 120% [99, 192], p = 0.027) compared with controls. Conclusions: Women with FHA had similar caloric intake to eumenorrheic controls but consumed more dietary protein, fiber, vitamin A, vitamin C, and iron. Future studies should examine the nutritional profiles of women with FHA in relation to long-term health consequences such as bone and vascular health.
Diagnosis and Management of Multiple Myeloma With Central Nervous System Involvement
D’Angelo, Christopher R., Godara, Amandeep , Lee, Hans C., Kumar, Shaji, D’Angelo, Christopher R. , Derman, Benjamin A. , Devarakonda, Srinivas , Lee, Hans C. , Robinson, Timothy, Kumar, Shaji , Callander, Natalie S.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | March 9, 2026 | Volume: 24 | Issue: 5 | Pages: No page available

10.6004/jnccn.2025.7105 | PMID 41825121 Get It

Extramedullary presentations of multiple myeloma (MM) involving the central nervous system (CNS) carry a dismal prognosis. Although historically rare, management of extramedullary disease—including CNS manifestations—has become increasingly clinically relevant as advances in systemic therapies have prolonged control of medullary disease. CNS manifestations may occur across a variety of clinical settings and at different time points throughout the disease course. Common symptoms include visual changes, headaches, loss of sensation, confusion, and seizures. MRI identifies leptomeningeal enhancement and/or parenchymal lesions in approximately 90% of cases, and lumbar puncture with cerebrospinal fluid testing for clonal plasma cell populations is confirmatory. Encouragingly, the incorporation of novel therapeutic agents has improved historically poor outcomes in CNS MM. Novel immunotherapeutic approaches using CAR T-cell therapy and bispecific T-cell–engaging antibodies have recently demonstrated significant efficacy in consolidating responses. Multimodality treatment strategies incorporating intrathecal chemotherapy, systemic novel agents, radiation therapy, and immunotherapy hold promise for achieving more durable responses in this devastating manifestation of MM.
Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study
Crowell, Cameron , Mankuzhy, Nikhil P. , Bennett, Julie , Bandopadhayay, Pratiti , Sturm, D., Green, Adam L. , Gupta, Tejpal , Chatterjee, Abhishek , Epari, Sridhar , Chinnaswamy, G., Prasad, Maya , Patel, Sonal, MacNeil, Mary , Vanan, Magimairajan , Larouche, Valérie , Renzi, Samuele , Jones, Jacquelyn , Perreault, Sébastien , Mata-Mbemba, Daddy , Sangatsuda, Yuhei , Yoshimoto, Koji , Lin, Emily , Feddersen, Charlotte R., Pavon-Mengual, Miriam, Vizzini, Olivia, Zápotocký, Michal, Popovacki, Aimee, Schlosser, Mary-Pat , Omene, Egiroh , Alexander, Kimberley L., Satgunaseelan, Laveniya, Williams, Andrew , Yao, Kristin, Ronsley, Rebecca , Cheng, Sylvia, Eisenstat, David, Andre, N., Matheson, K., Chan, Aimee , Lim-Fat, Mary Jane, Lapointe, Sarah , Cayrol, Romain , Coleman, Christina , Juretic, Nikoleta , McThenia, Sheila, Khan, Sara , Salloum, Ralph , Galvin, Robert , Hawkins, Cynthia, Karajannis, Matthias A. , Jones, David T.W., Ligon, K. L., Jabado, Nada, Erker, Craig , Sturm, Dominik , Chinnaswamy, Girish , Patel, Sohil H , Vanan, Magimairajan Issai , Feddersen, Charlotte , Cruz, Ofelia , Pavon-Mengual, Miriam , Vizzini, Olivia , Zápotocký, Michal , Popovacki, Aimee , Klawinski, Darren , Hansford, Jordan R , Schlosser, Mary-Pat , Omene, Egiroh , Alexander, Kimberley L , Satgunaseelan, Laveniya , Williams, Andrew , Yao, Kristin , Ronsley, Rebecca , Cheng, Sylvia , Ludlow, Louise , Eisenstat, David , Khuong-Quang, Dong-Anh , Tabouret, Emeline , André, Nicolas , Matheson, Kara , Chan, Aimee , Lim-Fat, Mary Jane , Lapointe, Sarah , Cayrol, Romain , Coleman, Christina , Juretic, Nikoleta , McThenia, Sheila , Khan, Sara , Wright-Nadkarni, Mariah , Salloum, Ralph , Galvin, Robert T , Sener, Ugur , Hawkins, Cynthia , Imber, Brandon S , Karajannis, Matthias A , Jones, David T W , Ligon, Keith L , Jabado, Nada , Erker, Craig , Larouche, Valérie , Hansford, Jordan R. , Satgunaseelan, Laveniya , Sener, Uğur , Hawkins, Cynthia

Mayo Clinic

Clinical Cancer Research | March 9, 2026 | Volume: 32 | Issue: 11 | Pages: 2243-2254

10.1158/1078-0432.ccr-25-3764 | PMID 41801141 Get It

Abstract Purpose: Knowledge of prognostic factors and long-term survival in patients with diffuse hemispheric glioma, H3 G34–mutant (DHG, H3 G34), remains limited in this tumor with a poor prognosis. Experimental Design: This retrospective, multi-institutional study investigated prognostic variables for patients with DHG, H3 G34, and their association with progression-free survival (PFS) and overall survival (OS). Uni- and multivariable Cox proportional hazard models were applied with multiple imputed datasets. Results: A total of 153 patients (142 G34R, 9 G34V, 2 via DNA methylation) were included. The median age at diagnosis was 17 years (range, 2–45). Initial gross/near total resection (GTR/NTR) was achieved in 43% of patients. Radiation was given in 91% (85% focal irradiation), and initial chemotherapy was given in 87% [70% temozolomide-based (TMZ), 25% TMZ/lomustine, 5% non-TMZ]. Median OS was 24 months [interquartile range (IQR), 22–28] with a median PFS of 14 months (IQR, 12–19). Twelve patients (8%) were found to be long-term survivors (≥5 years). Exploratory multivariable analysis showed that adjuvant radiotherapy [HR, 0.076; 95% confidence interval (CI), 0.033–0.17] and achieving GTR/NTR compared with &lt; NTR (HR, 0.51; 95% CI, 0.33–0.78) were associated with improved PFS. Multivariable analysis showed improved OS with increasing age at diagnosis (HR, 0.70; 95% CI, 0.57–0.87), initial radiotherapy (HR, 0.38; 95% CI, 0.15–0.96), and initial GTR/NTR compared with &lt; NTR (HR, 0.60; 95% CI, 0.37–0.97). Conclusions: This cohort highlights prognostic factors for patients with DHG, H3 G34, and describes relapse patterns and therapy approaches. Clinical trials and prospective registries are needed to improve outcomes.
Discriminating Between Fallers and Non-Fallers Using Kinematic Data from the Heel2Toe™ Wearable Sensor
Mayo, N., Abou-Sharkh, Ahmed , Dawes, Helen , Donkers, Sarah J. , Gillis, Chelsia, Goulding, Krista , Hill, Edward, Mate, Kedar , Tomita, Yosuke , Mayo, Nancy E , Mate, Kedar K V , Gillis, Chelsia , Hill, Edward Ted

Mayo Clinic

Sensors | March 9, 2026 | Volume: 26 | Issue: 5 | Pages: 1716

10.3390/s26051716 | PMID 41829678 Get It

Most falls occur while walking, making gait quality a logical therapeutic target. Many temporo-spatial variables have been implicated in increased fall risk, but these are dependent upon kinematic parameters of the joints involved in the gait cycle. The widespread availability of wearable sensors has made the acquisition of kinematic data feasible, and those related to the ankle are most relevant, as they relate most closely to causes of falls, trips, slips, and mis-steps. The purpose of this study is to estimate the extent to which measures of ankle angular velocity (AV) during walking are associated with falls. This is a comparative study of ankle AV metrics between people who have or have not experienced a fall in the past year. Data came from experimental use of the Heel2Toe™ sensor in a variety of settings, including demonstrations and clinical research studies. The sample comprised 387 participants, of whom 68 (17.6%) self-reported falling in the past year. Logistic regression with a natural cubic spline with 3 degrees of freedom identified AV of the angle at heel strike to discriminate between fallers and non-fallers, and the regression parameters were used to propose an algorithm to estimate fall risk. Applying the algorithm to the existing data yielded a range of probabilities from 0.0480 to 0.7245 depending on age of the person assessed. Further testing of this algorithm in different samples is warranted.
Minimally invasive myocardial infarction model recapitulates patient immune responses and reveals a pathogenic role for immature neutrophils
Möller-Ramon, Zoe , Kaltenbach, Anna Christina, Puhl, Sarah‐Lena , Kwok, Immanuel , Sicklinger, Florian, Jansen, Yvonne , Ernst, Annick, Nitz, Katrin , Schloss, Maximilian J. , Leuschner, Florian , Chan, Mark Yan Yee , Weber, Christian, Nitz, Katrin , Kaltenbach, Anna Cristina , Sicklinger, Florian , Weber, Christian , Steffens, Sabine , Duchêne, Johan

Mayo Clinic

No container title available | March 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.05.709757 Get It

Abstract Myocardial infarction (MI) triggers a systemic neutrophil response, yet the roles of distinct neutrophil subsets in cardiac remodeling remain unclear. Studying this requires murine models that accurately mirror human neutrophil dynamics. Here, we show that a minimally invasive intact-chest MI model is more pathophysiologically relevant than the standard open-chest approach for investigating post-MI immune responses. In the open-chest model, surgical trauma disrupts bone marrow homeostasis, releases large numbers of immature neutrophils, and masks MI-specific immune mechanisms. In contrast, the intact-chest model preserves bone marrow integrity and induces only a modest rise in circulating immature neutrophils, closely reflecting MI patient profiles. We further demonstrate that accumulation of immature neutrophils in the infarcted heart exacerbates cardiac dysfunction. Beyond neutrophils, the overall cardiac immune landscape differs markedly between both models. Collectively, our findings establish the intact-chest model as superior for studying post-MI inflammation and reveal immature neutrophils as mediators of adverse cardiac remodeling.
Guidelines for nutrition in adults with head and neck cancer: The American Society for Parenteral and Enteral Nutrition
Kiss, Nicole, Lewis, Whitney E, Mills, Jeannine B., Singh, Anurag K, Church, David D. , Mey, Jacob T. , Peterson, Sarah J. , Aguzzi, Kathleen, Bellini, Sarah Gunnell , Coelho, Maria Paula Villela, Cordwin, Laura, Duffy, Michael, Hager, Shanna J., Owen‐Michaane, Michael, Price, Kathleen C., Stanner, Heather , Storm, Bridget, Udagedara, Malika, McKeever, Liam , Church, David D , Mey, Jacob T , Peterson, Sarah , Bellini, Sarah , Coelho, Maria Paula Villela , Mundi, Manpreet S , Kiss, Nicole K. , Findlay, Merran , Frowen, Jacqui J. , Mundi, Manpreet S.

Mayo Clinic

Journal of Parenteral and Enteral Nutrition | March 8, 2026 | Volume: 50 | Issue: 3 | Pages: 274-338

10.1002/jpen.70067 | PMID 41773753 Get It

Abstract Background Head and neck cancer represents the seventh most common cancer diagnosis globally. Maintaining sufficient nutrition is important for preventing malnutrition (undernutrition) and muscle wasting, which contribute to worse outcomes, although many patients are unable to maintain adequate oral intake throughout treatment. This guideline provides practice guidance on nutrition care for patients with head and neck cancer. Methods An interdisciplinary team developed key questions and scanned results from a systematic search of the PubMed, EMBASE, CINAHL, and Cochrane Central databases back to 2001. Recommendations were created for key questions concerning timing and duration of nutrition support (early vs delayed enteral nutrition [EN], postoperative feeding, and perioperative dietitian intervention), frequency of dietitian and speech pathology consultations, nutrition screening and assessment, macronutrient requirements, enteral access devices, adjunctive strategies (appetite stimulants and continuation of oral intake alongside EN), specialized nutrients (arginine, glutamine, ω‐3, and immunonutrition), and interdisciplinary care. Results Ninety‐two studies were included. Recommendations were made supporting early initiation of EN when oral intake is inadequate, nutrition within 24 h after surgery, weekly consultation with a dietitian during radiotherapy, malnutrition screening and assessment with validated tools, interdisciplinary models of care, dietitian involvement before and after surgery, and when to consider use of specialized nutrients. Recommendations are also provided for protein intake (1.2–1.5 g/kg/day) and energy intake (≥30 kcal/kg/day). Conclusion This guideline provides guidance for the nutrition care of patients with head and neck cancer, identifies research gaps, and calls for standardized outcome reporting to further the state of the evidence. This paper was approved by the ASPEN Board of Directors.
Real-time diagnosis of adult T-cell leukemia/lymphoma using HBZ RNA in situ hybridization
Amador, Catalina , Poveda, Julio , Mohammed, Ibraheem, Hyjek, Elizabeth , Gibson, Sarah, Horna, Pedro , Rech, Karen L. , Ramos, Juan C, Delma, Katiana S, Koepplin, Justin W. , Cassidy, Daniel P. , DiCaudo, David J. , Sokol, Lubomir , Iqbal, Javeed , Chapman, Jennifer R. , Gibson, Sarah E. , Bouska, Alyssa , Hyjek, Elizabeth , Gibson, Sarah E , Horna, Pedro , Rech, Karen , Cassidy, Daniel P , Sokol, Lubomir , Iqbal, Javeed , Chapman, Jennifer R , Amador, Catalina , Hyjek, Elisabeth, Ramos, Juan Carlos , Delma, Katiana S. , Moscinski, Lynn C.

Mayo Clinic

American Journal of Clinical Pathology | March 7, 2026 | Volume: 165 | Issue: 5 | Pages: No page available

10.1093/ajcp/aqag030 | PMID 42106909 Get It

Abstract Objectives Diagnosing adult T-cell leukemia/lymphoma (ATLL) remains challenging due to its clinical and histopathologic heterogeneity. While HTLV-1 serology is a key diagnostic criterion, it is often unavailable at the time of diagnosis and does not confirm viral integration in tumor cells. The HTLV-1–encoded HBZ RNA is a reliable diagnostic biomarker for ATLL. We evaluated the diagnostic performance of RNAscope in situ hybridization (ISH) for HBZ RNA in formalin-fixed, paraffin-embedded (FFPE) tissues to distinguish ATLL from other T-cell lymphomas. Methods HBZ ISH was evaluated in 72 cases, including 52 ATLLs and 20 non-ATLL T-cell lymphomas, to determine diagnostic sensitivity and specificity, interobserver agreement, interlaboratory reproducibility, and comparison with digital gene expression. Results This assay demonstrated 86.5% sensitivity and 100% specificity, with sensitivity improving to 97% when excluding bone marrow clot sections and FFPE blocks older than 5 years. Interobserver agreement among 3 pathologists was excellent (κ = 0.92, percent agreement: 94%). Interlaboratory reproducibility of HBZ ISH was high, with 93% to 95% concordance across these Clinical Laboratory Improvement Amendments–certified laboratories. HBZ RNA ISH–positive cases demonstrated significantly higher HBZ gene expression levels by digital gene expression profiling. Conclusions We established HBZ ISH as a reliable tissue-based surrogate for HTLV-1 infection in ATLL. This assay will enhance diagnostic accuracy, expedite definitive diagnosis, and improve patient selection for targeted therapies and clinical trials, particularly in regions with a high prevalence of HTLV-1.
Gene Portals: A Framework for Integrating Clinical, Functional, and Structural Evidence into Rare Disease Variant Classification
Brünger, Tobias , Krey, Ilona , Kim, Suyeon, Klöckner, Chiara , Myers, Scott J, Johannesen, Katrine M. , Stefanski, Arthur , Taylor, Gary, Macnee, Marie , Dahl, Rebekka S., Yuan, Hongjie, Kim, Sukhan, Helbig, Ingo, Pan, Jen, Kurganov, Erkin , Baez, David, Zuberi, Sameer M., Lerche, Holger, May, Patrick, Ivaniuk, Alina, Meskis, Mary Anne , Hood, Veronica , Schust, Leah F., Freed, Amber, Froelich, Steven, Deng, Alexander T., Bouman, Arjan , Hajianpour, M.J. , Pal, Deb K. , Danvoye, Leslie, Lederer, Damien , BALCI, TUĞÇE, Hagebeuk, Eveline , Heidlebaugh, Alexis R. , Oetjens, Kathryn F., Striano, Pasquale, Williams, Sarah Drewes, Engelen, Kalene van , Howell, Katherine B. , Khoury, Jean , Benke, Tim A., Strehlow, Vincent , Platzer, Konrad, Ramsey, Amy J, Manaster, Lisa, Malepati, Sunitha, Fox, Pangkong M., Noebels, Jeffrey, Chung, Wendy, Poduri, Annapurna, Stripe, Laina Lusk, Ruggiero, Sarah M., Cohen, Stacey, Wilmarth, Olivia, Prentice, Anna Jenne, Cha, Esther, Budnik, Nikita , Kramer, Audra A. , Gh, Zhang, Palotie, Aarno, Daly, Mark J., Møller, R., Lemke, Johannes R., Lal, Dennis , Møller, Rikke S. , May, Patrick , Bruenger, Tobias , Pan, Jen Q , Farrant, Mark , Wyllie, David J A , Bosselmann, Christian , Mantegazza, Massimo , May, Patrick , Ivaniuk, Alina , Goodspeed, Kimberly , Trinidad, Marena , Aledo-Serrano, Ángel , Pal, Deb K , Platzer, Konrad , Ruggiero, Sarah M , Daly, Mark J. , George, Alfred L , Brunklaus, Andreas , Møller, Rikke S , Myers, Scott J. , Taylor, Gary, Pérez‐Palma, Eduardo , Schorge, Stéphanie , Dahl, Rebekka S. , Perszyk, Riley E. , Bajaj, Sunanjay , Helbig, Ingo , Wollmuth, Lonnie P. , Báez-Nieto, David , Zuberi, Sameer M. , Boßelmann, Christian M. , Mantegazza, Massimo , Cestèle, Sandrine , Ivaniuk, Alina , Kang, Jing‐Qiong , Gati, Cornelius , Montanucci, Ludovica , Wüster, Arthur , Deng, Alexander T. , Borovikov, Artem O. , Sharkov, Artem A. , Bouman, Arjan , Hoffman, Trevor L. , Howell, Katherine B. , Benke, Tim A. , Platzer, Konrad , Ramsey, Amy J. , Fox, Pangkong , Noebels, Jeffrey L. , Chung, Wendy K. , Poduri, Annapurna , Lusk, Laina G. , Cohen, Stacey , Smith, Lacey A. , Boesch, Sylvia , Prentice, Anna Jenne , Hommersom, Marina P. , Vanoye, Carlos G. , Nothnagel, Michael , Palotie, Aarno V. , George, Alfred L. , Zárate, Yuri A. , Brunklaus, Andreas , Traynelis, Stephen F. , Lemke, Johannes R.

Mayo Clinic

No container title available | March 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.05.26347086 | PMID 41822692 Get It

Abstract Rare Mendelian disorders affect 300-400 million people globally. Although genetic testing has become widely adopted, gene-specific evidence for tailored variant interpretation remains scattered across resources. We present Gene Portals, a framework for gene-centered multimodal knowledge bases that co-localize expert-harmonized clinical data, functional assays, population variation, structural annotations and gene-specific ACMG/AMP specifications within a single resource. A modular interface integrates this unified evidence with VCEP-refined ACMG specifications to enable automated gene-specific variant classification, infer molecular mechanisms, and support cross-gene analyses. We demonstrate the framework’s utility across five Gene portals spanning eleven neurodevelopmental disorder-associated genes, integrating data from 4,423 individuals with 2,838 unique variants, 36,149 ClinVar submissions, and 1,044 expert-curated molecular readouts. By organizing evidence that is otherwise dispersed across multiple sources into a unified, queryable framework, the SCN, GRIN, CACNA1A, SATB2 and SLC6A1 Gene Portals became widely used community resources and provide an extensible template for standardized rare-disease variant interpretation and mechanism-aware discovery.